DeCure's autonomous Cancer AI scientist is researching a drug-repurposing hypothesis for benign vaginal neoplasm — screening already-approved drugs against its 1-gene Open Targets disease module to publish open-access research. Research is fast; the path to publication is funded in milestone stages.
Disease moduleBenign vaginal neoplasm maps to a 1-gene Open Targets module — the target space DeCure's AI scientist screens approved drugs against.
DeCure.ai methodSignature reversal (LINCS) plus network proximity (STRING) rank already-approved drugs likely to perturb this module — the same engine that produces DeCure.ai's repurposing hypotheses.
Repurposing thesisScreening approved medicines against this disease module, then publishing the evidence for the strongest candidate. Known pharmacology and human exposure data make the first question sharper — they do not establish safety or efficacy in a new indication.
Research record
01
ResearchComing soon
Candidate research + dossier — target rationale, drug-repurposing thesis and evidence pack.proof: Published dossier + on-chain hash
02
ValidationComing soon
In-vitro biological validation at a contract research org (CRO).proof: CRO contract + in-vitro report
03
Peer review & paperComing soon
Peer-reviewed paper published open-access (preprint + journal).proof: DOI + open-access link + on-chain hash
Current lead
No approved-drug candidate for benign vaginal neoplasm is corroborated in the literature DeepSearch retrieved. Some conditions are managed with non-pharmacological care — a device, surgery or physical therapy — rather than a medicine; that may be the case here, or the literature we found may simply be too sparse yet to support a drug-repurposing angle.
What the evidence adds up to
The 2010 review of pseudoneoplastic lesions of the female genital tract describes numerous benign, proliferative, or reactive processes—often linked to hormone stimulation or inflammation—that can mimic benign or malignant tumours. Examples include microglandular hyperplasia of the cervix mimicking endometrial adenocarcinoma, reactive epithelial changes in the fallopian tubes mimicking carcinoma, and pregnancy-related ovarian changes such as pregnancy luteoma that may mimic ovarian neoplasms. The authors conclude that many such benign hyperplastic or reactive processes can be mistaken for neoplasms both clinically and pathologically, and that awareness of their features is needed to prevent overtreatment of benign conditions. No specific drug treatments are discussed.
A 2017 case report describes a primary vaginal carcinosarcoma (VCS) in a postmenopausal patient with complete uterine prolapse. VCS is noted to be a rare and clinically aggressive neoplasm, and the case was unusual because the tumour was closely associated with differentiated squamous intraepithelial neoplasia (DSIN), from which it appeared to have arisen. The authors state that clear management guidelines and optimal therapy for primary vaginal malignancies have not been determined. No drug therapy is mentioned.
A 1978 case report describes a mucinous carcinoma of anal duct origin that presented clinically as a vaginal cyst. The authors note that the vast majority of vaginal submucosal cysts are benign lesions, and that primary malignant tumours of the vagina are infrequent and mostly mucosal. They emphasise the importance of considering anal neoplasia in the differential diagnosis of cystic vaginal lesions. No drug treatment is discussed.
Across these abstracts, no drug is proposed or tested for benign vaginal neoplasms. The literature focuses entirely on diagnostic distinction between benign and malignant lesions. What remains missing is any clinical trial, any drug repurposing hypothesis, any patient stratification, and any funding for treatment research in this specific disease category.
Evidence
Retrieved by DeepSearch across 234,678,978 indexed works and resolved on OpenAlex — ranked by citations, including the results that did not work.
PubMed · 2010 · 18 citations
Pseudoneoplastic lesions of the female genital tract.
AbstractCONTEXT: Numerous benign, proliferative, or reactive processes, often related to hormone stimulation or inflammation, occur throughout the female genital tract and may mimic benign or malignant tumors. Several of the more common pseudoneoplastic lesions are discussed in this article, including microglandular hyperplasia of the cervix mimicking well-differentiated endometrial adenocarcinoma, reactive epithelial changes in the fallopian tubes mimicking adenocarcinoma or carcinoma in situ, and pregnancy changes in the ovary including pregnancy luteoma and large solitary luteinized follicular cyst of pregnancy and puerperium that may mimic ovarian neoplasms. OBJECTIVES: To discuss and illustrate several common lesions of the female genital tract that mimic neoplasms. DATA SOURCES: Material derived from consultation cases and review of the literature. CONCLUSIONS: Many benign hyperplastic or reactive processes that occur in the female genital tract may be mistaken for neoplasms both clinically and pathologically. Awareness of the features of such lesions will aid in their correct diagnosis and prevent overtreatment of benign processes.
International Journal of Surgical Pathology · 2017 · 11 citations
Primary Carcinosarcoma of the Vagina Associated With Differentiated Squamous Intraepithelial Neoplasia in a Patient With Complete Uterine Prolapse: Case Report and Review of the Literature
AbstractVaginal carcinosarcomas (VCSs) are rare and clinically aggressive neoplasms. Primary vaginal malignancies are among the rarest malignant tumors, so clear management guidelines and optimal therapy, especially in the presence of significant pelvic organ prolapse, has not been determined. Here, we present a case of primary VCS closely associated with differentiated squamous intraepithelial neoplasia (DSIN), from which it appeared to have arisen in a postmenopausal patient with complete uterine prolapse. The unusual presentation of our case with DSIN in the adjacent vaginal epithelium with possible diagnostic pitfalls emphasizes the need for systemic presentation of these cases to help pathologists and clinicians know that such lesions can initially present in a patient with complete uterine prolapse. To our knowledge, this is the first case of vaginal DSIN described in the literature to date.
Mucinous carcinoma of anal duct origin presenting clinically as a vaginal cyst
AbstractThe vast majority of vaginal submucosal cysts are benign lesions. Primary malignant tumors of the vagina are infrequent and most are mucosal lesions. A case is described in which an unusual neoplasm, anal duct carcinoma, presented clinically as a vaginal lesion. The importance of considering anal neoplasia in the differential diagnosis of cystic vaginal lesions is noted.
Disease module: DeepOracle (Open Targets). Structures: RDKit from PubChem SMILES. Literature: retrieved by DeepSearch across 234,678,978 indexed works (targeted per-candidate search), resolved on OpenAlex.
DeCure is a research and publication project, not medical advice and not a treatment. "DeCure for X" describes a research goal, not a claim that a cure exists. Backing a cure is a contribution to fund the research — it is not an investment, and confers no yield, royalty, equity or IP ownership. Papers are published open-access by the DeCure.ai DAO.
